Surgery Medical News about Gallbladder Cancer

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Evolving treatment strategies for gallbladder cancer
Annals of Surgical Oncology, 06/09/09

Hueman MT et al. - In a review of evolving treatment strategies for gallbladder cancer, it seems that although data for adjuvant therapy following resection are limited, some data do suggest a survival benefit for adjuvant chemoradiation therapy. Management of pts with gallbladder cancer requires a multidisciplinary approach with input from a surgeon skilled in hepatobiliary surgery.

Methods

In the era of laparoscopic cholecystectomy, incidental gallbladder cancer has dramatically increased and now constitutes the major way pts present with gallbladder cancer.
While pts with incidental gallbladder cancer have a better survival than pts with nonincidental gallbladder cancer, incidental gallbladder cancer can be associated with a varied prognosis.
Imaging with computed tomography (CT), magnetic resonance imaging (MRI), and [18]F-fluorodeoxyglucose (FDG) positron emission tomography (PET), as well as diagnostic laparoscopy, all have varying roles in the workup of pts with incidental gallbladder cancer.
For pts with T1b, T2, and T3 incidental gallbladder cancer, re-resection is generally recommended.

Results

At re-exploration, many pts with incidental gallbladder cancer will have residual disease.
Definitive oncologic management requires re-resection of the liver, portal lymphadenectomy, and attention to the common bile duct.
Extent of hepatic resection should be dictated by the ability to achieve a microscopically negative (R0) margin.
Routine resection of the common bile duct is unnecessary but should be undertaken in the setting of a positive cystic duct margin.
If an incidental gallbladder cancer is discovered at the time of surgery, whether the surgeon should directly proceed with a more definitive oncologic operation should depend on the surgeon’s skill-set and experience.
Gallbladder cancer has a propensity to recur.

<< Previous
Liver resection for metastatic colorectal cancer in patients with...

Next >>
Is there a subset of patients with preoperatively diagnosed N2...

Unsuspected Gallbladder Cancer Diagnosed After Laparoscopic Cholecystectomy: Focus on Acute Cholecystitis
World Journal of Surgery, 11/11/09 Relevance Score: 66%

An evidence-based consensus statement on the role and application of endosonography in clinical practice
Endoscopy, 10/30/09 Relevance Score: 66%

Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials
British Journal of Cancer, 11/13/09 Relevance Score: 64%

Frequent and Significant K-ras Mutation in the Pancreas, the Bile Duct, and the Gallbladder in Autoimmune Pancreatitis
Pancreas, 10/23/09 Relevance Score: 64%

Incidental Gallbladder Cancer Diagnosed Following Laparoscopic Cholecystectomy
World Journal of Surgery, 10/19/09 Relevance Score: 64%